REFERENCES
- Santolaya ME, Alvarez AM, Avilés CL, Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Pediatr Infect Dis J. 2007;26:794–798.
- Paganini HR, Aguirre C, Puppa G, A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer. 2007;109:2572–2579.
- Freifeld AG, Bow EJ, Sepkowitz KA, Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52:e56–e93.
- Manji A, Lehrnbecher T, Dupuis LL, A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia. Pediatr Infect Dis J. 2012;31:353–358.
- Le Guyader N, Auvrignon A, Vu-Thien H, Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children. Support Care Cancer 2004;12:720–724.
- Aksoylar S, Cetingül N, Kantar M, Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatr Hematol Oncol. 2004;21:115–123.
- Corapcioglu F, Sarper N, Zengin E. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Pediatr Hematol Oncol. 2006;23:177–186.
- Vural S, Erdem E, Gulec SG, Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Pediatr Int. 2010;52:262–267.
- Ichikawa M, Suzuki D, Ohshima J, Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia. Pediatr Blood Cancer. 2011;57:1159–1162.
- Bodey G, Abi-Said D, Rolston K, Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients. Eur J Clin Microbiol Infect Dis. 1996;15:625–634.
- Winston DJ, Bartoni K, Bruckner DA, Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis. 1998;26:576–583.
- Demir HA, Kutluk T, Ceyhan M, Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors. Pediatr Hematol Oncol. 2011;28:299–310.
- Karaman S, Vural S, Yildirmak Y, Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia. Pediatr Blood Cancer. 2012;58:579–583.
- El-Haddad AMA. Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients. Curr Ther Res Clin Exp. 1995;56:1094–1099.
- Uygun V, Karasu GT, Ogunc D, Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study. Pediatr Blood Cancer. 2009;53:610–614.
- Furno P, Bucaneve G, Del Favero A. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis. 2002;2:231–242.
- Oguz A, Karadeniz C, Citak EC, Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Pediatr Hematol Oncol. 2006;23:245–253.
- Kebudi R, Görgün O, Ayan I, Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors. Med Pediatr Oncol. 2001;36:434–441.
- Rackoff WR, Ge J, Sather HN, Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 1999;21:260–267.
- van Hoff J, Berg AT, Seashore JH. The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol. 1990;8:1255–1262.